Clinical Trial Update: Exploratory Study of KPI-121 Effect on Intra- or Subretinal Fluid Due to Retinal Vein Occlusion/Diabetic Macular Edema [NA]

View source ↗

Summary

Exploratory study of KPI-121 on intra- or subretinal fluid due to retinal vein occlusion and diabetic macular edema has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Retinal Vein Occlusion

Drugs mentioned

• KPI-121

Snippet

Sponsor: Kala Pharmaceuticals, Inc. | Conditions: Retinal Vein Occlusion, Diabetic Macular Edema | NA | Status: COMPLETED | Results posted: 2020-12-10